Studies on the metabolism and the toxicological analysis of the nootropic drug fipexide in rat urine using gas chromatography-mass spectrometry

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 804, Issue 2, 2004, Pages 337-343

  Staack, Roland F ^a   Maurer, Hans H ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Fipexide; Metabolism

Indexed keywords

ACETYLATION; BODY FLUIDS; GAS CHROMATOGRAPHY; HYDROLYSIS; MASS SPECTROMETRY; METABOLISM;

LIQUID-LIQUID EXTRACTION;

BIOMEDICAL ENGINEERING;

1 (3,4 METHYLENEDIOXYBENZYL)PIPERAZINE; 4 CHLOROPHENOXYACETIC ACID; DIAMINE DERIVATIVE; DRUG METABOLITE; FIPEXIDE; N (3,4 METHYLENEDIOXYBENZYL)ETHYLENEDIAMINE; N (4 HYDROXY 3 METHOXYBENZYL)PIPERAZINE; N [2 (4 CHLOROPHENOXY)ACETYL]ETHYLENEDIAMINE; NOOTROPIC AGENT; PIPERAZINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG ACETYLATION; DRUG HYDROLYSIS; DRUG METABOLISM; GAS CHROMATOGRAPHY; LIQUID LIQUID EXTRACTION; MALE; MASS SPECTROMETRY; METABOLITE; NONHUMAN; PRIORITY JOURNAL; RAT; TOXICITY TESTING; URINE;

ANIMALS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; NOOTROPIC AGENTS; PIPERAZINES; RATS;

EID: 1842687182     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2004.01.035     Document Type: Article

References (44)

1. Bompani R., Scali G. Curr. Med. Res. Opin. 10:1986;99.
2. Marino A., Florio T., Meucci O., Landolfi E., Grimaldi M., Ventra C., Schettini G. Pharmacol. Res. 22:1990;179.
3. David G., Friedman J., Michaud G., Marmo G., Pierre R. Acta Therapeut. 11:1985;387.
4. Lucchi L., Govoni S., Spano P.F., Trabucchi M. Brain Res. 398:1986;212.
5. Genkova P.M., Lazarova B.M. Acta Physiol. Pharmacol. Bulg. 14:1988;36.
6. Genkova P.M., Lazarova B.M. Eur. Neuropsychopharmacol. 6:1996;285.
7. Rolandi E., Franceschini R., Marabini A., Messina V., Bongera P., Barreca T. Br. J. Clin. Pharmacol. 18:1984;236.
8. Durand F., Samuel D., Bernuau J., Saliba F., Pariente E.A., Marion S., Benhamou J.P., Bismuth H. J. Hepatol. 15:1992;144.
9. Mion F., Descos L., Gerard F., Vial T. Gastroenterol. Clin. Biol. 14:1990;513.
10. Guy C., Blay N., Rousset H., Fardeau V., Ollagnier M. Therapie. 45:1990;429.
11. Maurer H.H. Comb. Chem. High Throughput Screen. 3:2000;461.
12. H.H. Maurer, in: J. Yinon (Ed.), Advances in Forensic Applications of Mass Spectrometry, CRC Press, Boca Raton, FL, 2003, p. 1.
13. Staack R.F., Fehn J., Maurer H.H. J. Chromatogr. B. 789:2003;27.
14. Paul L.D., Maurer H.H. J. Chromatogr. B. 789:2003;43.
15. A. Shulgin, in: Dan Joy (Ed.), Pihkal: A Chemical Love Story, Transform Press, Berkley, CA, 1991, p. 815.
16. D. Trachsel, N. Richard, Psychedelische Chemie, Nachtschatten Verlag, Solothurn, 2000.
17. Maurer H.H., Bickeboeller-Friedrich J. J. Anal. Toxicol. 24:2000;340.
18. Bickeboeller-Friedrich J., Maurer H.H. Ther. Drug Monit. 23:2001;61.
19. Staack R.F., Fritschi G., Maurer H.H. J. Chromatogr. B. 773:2002;35.
20. Staack R.F., Fritschi G., Maurer H.H. J. Mass Spectrom. 38:2003;971.
21. Kraemer T., Bickeboeller-Friedrich J., Maurer H.H. Drug Metab. Dispos. 28:2000;339.
22. McKay A.F., Ott W.L., Taylor G.W., Buchanan M.N., Crooker J.F. Can. J. Res. 28:1950;683.
23. Maurer H.H. Spectrosc. Eur. 6:1994;21.
24. K. Pfleger, H.H. Maurer, A. Weber, Mass Spectral Library of Drugs, Poisons, Pesticides, Pollutants and their Metabolites, Agilent Technologies, Palo Alto, CA, 2004, in press.
25. R.F. Staack, H.H. Maurer, J. Mass Spectrom., 2004, in press.
26. Maurer H.H., Kraemer T. Arch. Toxicol. 66:1992;675.
27. Ensslin H.K., Kovar K.A., Maurer H.H. J. Chromatogr. B. 683:1996;189.
28. Ensslin H.K., Maurer H.H., Gouzoulis E., Hermle L., Kovar K.A. Drug Metab. Dispos. 24:1996;813.
29. Maurer H.H. Ther. Drug Monit. 18:1996;465.
30. Kraemer T., Vernaleken I., Maurer H.H. J. Chromatogr. B. 702:1997;93.
31. Kraemer T., Maurer H.H. J. Chromatogr. B. 713:1998;163.
32. R.F. Staack, D.S. Theobald, H.H. Maurer, Ther. Drug Monit., 2004, in press.
33. F.W. McLafferty, F. Turecek, Interpretation of Mass Spectra, University Science Books, Mill Valley, CA, 1993.
34. R.M. Smith, K.L. Busch, Understanding Mass Spectra - A Basic Approach, Wiley, New York, NY, 1999.
35. R.B. Silverman, The Organic Chemistry of Drug Design & Drug Action, Academic Press, London, 1992.
36. Staack R.F., Maurer H.H. J. Anal. Toxicol. 27:2003;560.
37. R.F. Staack, D.S. Theobald, L.D. Paul, D. Springer, T. Kraemer, H.H. Maurer, Xenobiotica, 2004, in press.
38. Kovats E. Helv. Chim. Acta. 41:1958;1915.
39. R.A. de-Zeeuw, J.P. Franke, H.H. Maurer, K. Pfleger, Gas Chromatographic Retention Indices of Toxicologically Relevant Substances and their Metabolites (Report of the DFG Commission for Clinical Toxicological Analysis, special issue of the TIAFT Bulletin), VCH Publishers, Weinheim, New York, Basle, 1992.
40. H.H. Maurer, in: K. Pfleger, H.H. Maurer, A. Weber (Eds.), Mass Spectral and GC Data of Drugs, Poisons, Pesticides, Pollutants and their Metabolites, Part 4, Wiley-VCH, Weinheim, 2000, p. 3.
41. K. Pfleger, H.H. Maurer, A. Weber, Mass Spectral and GC Data of Drugs, Poisons, Pesticides, Pollutants and their Metabolites, Part 4, Wiley-VCH, Weinheim, 2000.
42. K. Pfleger, H.H. Maurer, A. Weber, Mass Spectral and GC Data of Drugs, Poisons, Pesticides, Pollutants and their Metabolites, Part 5, Wiley-VCH, Weinheim, 2004, in press.
43. Staack R.F., Maurer H.H. J. Chromatogr. B. 798:2003;333.
44. ABDATA, List of pharmaceutical substances, Werbe- und Vertriebsgesellschaft Deutscher Apotheker, Eschborn, Germany, 2000.